Nordion Inc Com (NYSE:NDZ)

CAPS Rating: 4 out of 5

Global health and life sciences company that provides enabling technologies, products, and services to improve the delivery of healthcare worldwide. Primary focuses are drug development and disease diagnosis.

Results 1 - 4 of 4

Recs

0
Member Avatar projectchris (< 20) Submitted: 1/23/2010 3:59:32 PM : Outperform Start Price: $7.35 NDZ Score: -10.41

Chalk river will be online again soon barring some unexpected event. I also think the price now has downside protection.

Recs

1
Member Avatar Charboul (< 20) Submitted: 10/6/2008 10:01:56 PM : Outperform Start Price: $10.35 NDZ Score: -72.41

This Company is doing well. There are a lot of Changes going on, but once things settles, it will move up fast.

Recs

1
Member Avatar DTBoojum (79.93) Submitted: 9/10/2007 11:36:56 AM : Outperform Start Price: $19.05 NDZ Score: -81.78

check mithrophon's pitch on Liquid Lounge, doesn't seem like a steal but something worth following

Recs

0
Member Avatar cancerman (88.71) Submitted: 1/30/2007 7:19:51 PM : Outperform Start Price: $16.25 NDZ Score: -73.51

MDCC acquisition adds real value.
FDA troubles are behind them.
Sold off diagnostic unit to concentrate on life science and drug discovery.
New upper management has been tested by these issues and done well.
A $2.5B cap

Results 1 - 4 of 4

Featured Broker Partners